Back to top

rsi: Archive

Zacks Equity Research

Down -8.57% in 4 Weeks, Here's Why You Should You Buy the Dip in Nutanix (NTNX)

Nutanix (NTNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NTNXNegative Net Change

Zacks Equity Research

Down -8.54% in 4 Weeks, Here's Why You Should You Buy the Dip in Alcoa (AA)

The heavy selling pressure might have exhausted for Alcoa (AA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

AANegative Net Change

Zacks Equity Research

Logitech (LOGI) Loses -7.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Logitech (LOGI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

LOGIPositive Net Change

Zacks Equity Research

Spotify (SPOT) Loses -7.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Spotify (SPOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SPOTPositive Net Change

Zacks Equity Research

Down -9.12% in 4 Weeks, Here's Why You Should You Buy the Dip in Antero Resources (AR)

The heavy selling pressure might have exhausted for Antero Resources (AR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ARNegative Net Change

Zacks Equity Research

TransDigm (TDG) Loses -5.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

TransDigm (TDG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TDGPositive Net Change

Zacks Equity Research

Down -5.5% in 4 Weeks, Here's Why Brinker International (EAT) Looks Ripe for a Turnaround

Brinker International (EAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

EATNegative Net Change

Zacks Equity Research

RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for RxSight (RXST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

RXSTPositive Net Change

Zacks Equity Research

After Plunging -46.98% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

NGL Energy Partners (NGL) Loses -5.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

NGL Energy Partners (NGL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NGLNegative Net Change

Zacks Equity Research

After Plunging -47.01% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround

HilleVax (HLVX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HLVXNegative Net Change

Zacks Equity Research

Here's Why Greenbrier (GBX) is Poised for a Turnaround After Losing -14.76% in 4 Weeks

The heavy selling pressure might have exhausted for Greenbrier (GBX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

GBXPositive Net Change

Zacks Equity Research

Down -23.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Clean Energy Fuels (CLNE)

The heavy selling pressure might have exhausted for Clean Energy Fuels (CLNE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CLNENegative Net Change

Zacks Equity Research

Down -19.96% in 4 Weeks, Here's Why You Should You Buy the Dip in Calavo (CVGW)

The heavy selling pressure might have exhausted for Calavo (CVGW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CVGWPositive Net Change

Zacks Equity Research

After Plunging -11.25% in 4 Weeks, Here's Why the Trend Might Reverse for EQT (EQT)

EQT (EQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

EQTNegative Net Change

Zacks Equity Research

Down -6.43% in 4 Weeks, Here's Why You Should You Buy the Dip in International Seaways (INSW)

International Seaways (INSW) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

INSWNegative Net Change

Zacks Equity Research

Down -7.69% in 4 Weeks, Here's Why You Should You Buy the Dip in Teekay Tankers (TNK)

Teekay Tankers (TNK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

TNKPositive Net Change

Zacks Equity Research

Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)

Cellectis (CLLS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CLLSPositive Net Change

Zacks Equity Research

Here's Why Melco (MLCO) is Poised for a Turnaround After Losing -18.13% in 4 Weeks

The heavy selling pressure might have exhausted for Melco (MLCO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MLCOPositive Net Change

Zacks Equity Research

Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)

uniQure (QURE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

QUREPositive Net Change

Zacks Equity Research

CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for CryoPort (CYRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CYRXNegative Net Change

Zacks Equity Research

Down -5.13% in 4 Weeks, Here's Why You Should You Buy the Dip in TriMas (TRS)

The heavy selling pressure might have exhausted for TriMas (TRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

TRSPositive Net Change

Zacks Equity Research

After Plunging -13.21% in 4 Weeks, Here's Why the Trend Might Reverse for PDD Holdings Inc. Sponsored ADR (PDD)

The heavy selling pressure might have exhausted for PDD Holdings Inc. Sponsored ADR (PDD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PDDNegative Net Change

Zacks Equity Research

Prima BioMed (IMMP) Loses -34.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Prima BioMed (IMMP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

IMMPPositive Net Change